June 2023 – Page 2 – Policy & Medicine

Industry Pushing Back on Medicare Drug Price Negotiations

FDA Seeking Comments on Quantitative Claims in DTC Prescription Drug Advertising

Magellan Executives Charged with Conspiracy, Wire Fraud, and FDA Violations

Bipartisan Senators Ask for Additional Guidance on Transparency in Coverage Rule

Congress Seeking Answers on Hospital Price Transparency Rule Compliance

CMS Fines Hospital for Noncompliance with Hospital Price Transparency Rule

House Subcommittee Focuses on Antimicrobial Resistance

SouthEast Eye Specialists to Pay $17 Million to Resolve Anti-Kickback and False Claims Act Allegations

FDA to Require Mail-Back Envelopes for Opioids Dispensed in Outpatient Settings

CCO MATE ACT DEA Resource Center Includes, Courses, Frequently Asked Questions (FAQ’s) and Additional Resources